It can be seen from the figure that cellular tumor antigen p53 (TP53), signal transducer and activator of transcription 3 (STAT3), SRC, and CASP3 may be the core targets of C nutans in the treatment of RCC. Here, TP53 is linked to renal cell carcinoma.